Lv1
10 积分 2025-10-13 加入
Famitinib: First Approval
4个月前
已完结
Metabolism and bioactivation of famitinib, a novel inhibitor of receptor tyrosine kinase, in cancer patients
4个月前
已完结
Overall survival with camrelizumab plus famitinib versus camrelizumab alone and investigator's choice of chemotherapy for recurrent or metastatic cervical cancer
4个月前
已完结
Advances in non-viral mRNA delivery to the spleen
5个月前
已完结
Targeted Drug Delivery to the Spleen and Its Implications for the Prevention and Treatment of Cancer
5个月前
已完结
Spleen‐Targeted mRNA Nanoparticles for Modulating B Cell Hyperactivation in Rheumatoid Arthritis Therapy
5个月前
已完结
Fluorinated Ionizable Lipids for Efficient Spleen-Targeted mRNA Delivery in Cancer Immunotherapy
5个月前
已完结
Recent advancements in design of nucleic acid nanocarriers for controlled drug delivery
7个月前
已完结
Enantioselective Synthesis of cis‐Decalins by Merging the Birch Reduction and Inverse‐Electron‐Demand Diels–Alder Reaction
7个月前
已完结
Rapid Enantioselective and Diastereoconvergent Hybrid Organic/Biocatalytic Entry into the Oseltamivir Core
7个月前
已完结
皖公网安备34019202002308
